HNHacker News
TopNewBestAskShowJobs

estearum

5,152 karma · joined July 31, 2025

submissionscomments
estearum··on The U.S. Is Driving Away Young Scientists
Why not instead of being a defeatist whiner and contributing to the impression that there's no need for justice and consequences, you actually demand justice and consequences? Too much work to call your representatives?

5calls.org

Figuring out the right amount of justice-seeking versus forgiveness is the top point of argument right now among the newly elected dominant party.

You want to toss your vote in the "let's just move on" bucket?

estearum··on The U.S. Is Driving Away Young Scientists
It's a valid criticism but no, it actually did not "kill" research, as evidenced by the US's extreme concentration and outperformance on any relevant scientific metric per capita.
estearum··on Fossil CO2 emissions decrease in 2026
Is instability only instability if it's the right shape or color or flavor?

The point is that the radical change that was "so easy" during COVID was 1) forced by an emergency, and 2) triggered a stream of emergencies that we're still dealing with today across the entire world.

If GP meant "radical change is easy so long as you can accept a stream of emergencies with uncertain outcomes for an indefinite amount of time into the future," then sure... radical change is easy!

estearum··on Fossil CO2 emissions decrease in 2026
Go read some books on how coups work and the numerous historical examples. This comment is just too full of either bad faith or too-far-afield misunderstandings to be rectified in an HN comment thread.
estearum··on Fossil CO2 emissions decrease by 0.4% in 2026
If you think the "killing the people in charge" is the hard part of radical change, then you haven't read much history.
estearum··on Fossil CO2 emissions decrease in 2026
The event after which dozens of governments were destabilized and incumbents were ousted from power all over the world… convinced you that radical change is easy…?

The United States was a couple feet from an actual coup dude.

estearum··on Silicon Valley Promises AI Will Cure Disease. Drugmaker CEOs Aren't Buying It
> They've already been proven in the other countries -- higher numbers of patients than you have in normal clinical trials -- but because the approval rules are excessively rigid and unreasonable, that doesn't count.

You are wrong. You absolutely can get drugs approved in the US based on real-world studies or observational data. The reason this happens so infrequently is actually because it's virtually impossible to prove a drug is safe and effective using real-world studies or observational data.

We don't rely on (super expensive) RCTs because FDA says you need RCTs. We rely on them because FDA says you need to prove your drugs are safe and effective, and no one knows a better/cheaper/faster way to do that than RCTs.

You can absolutely bundle up a bunch of observational data and file for approval. You likely won't get it, not because observational data isn't allowed, but that observational data almost certainly cannot prove the claims you're making. Drug makers know this, so they don't even try. But you're welcome to!

estearum··on Silicon Valley Promises AI Will Cure Disease. Drugmaker CEOs Aren't Buying It
1) No, not even theoretically. Since "prove" means different things to different organizations.

2) I didn't say there are no additional requirements. For example, you have to fill out some paperwork. I said they are trivial compared to actually making a drug that works and proving that it works. Drugs do not die because of the approval processes, they die because it's unfathomably hard to make drugs that work and then to prove that they work.

estearum··on Silicon Valley Promises AI Will Cure Disease. Drugmaker CEOs Aren't Buying It
It's not an AI-shaped problem. The mapping from inputs to outputs is something like "the most complex process humans are aware of." You're trying to map a chemical in a pill (or a shot) from the organism down to organs down to cells, through the metabolome, proteome, genome, and so on, both down then back up, until you get back to "outcome that a human being feels positively about."
estearum··on Silicon Valley Promises AI Will Cure Disease. Drugmaker CEOs Aren't Buying It
Because "fully automated lab" doesn't include "put it into humans and observe them for years."

It's trivial to make drugs that are as-promising as working drugs in the lab, but then end up not to be actually working drugs in people.

estearum··on Silicon Valley Promises AI Will Cure Disease. Drugmaker CEOs Aren't Buying It
No they're not lol.

Put some numerical values to "wide" please, so we can establish whether we mean the same thing by it.

I would be shocked to hear that more than 1% of Americans are using "grey market peptides," and I would be more shocked to hear that <1% usage is considered "wide" in anyone's book.

estearum··on Silicon Valley Promises AI Will Cure Disease. Drugmaker CEOs Aren't Buying It
The obvious response is the mass-market success of a drug that was approved by the traditional approval process? And in fact didn't even achieve mass market use until it was approved specifically for weightloss?

That's as far as you can get from "grey market."

estearum··on Silicon Valley Promises AI Will Cure Disease. Drugmaker CEOs Aren't Buying It
To clarify, it's not the approval process that's challenging. It's making a safe and effective drug, then proving that it's safe and effective. If you achieve those, approval is pretty much trivial.
estearum··on Silicon Valley Promises AI Will Cure Disease. Drugmaker CEOs Aren't Buying It
> All AI has to do is catch problems earlier in the pipeline to outcome success rates.

Which it has shown no ability to do, so far.

estearum··on Ozempic-style drugs now in trials for heart failure, addiction and even aging
No, you can know that decisions are stupid before knowing their outcome. In fact, decisions can be stupid even when they result in a neutral or positive outcome.
estearum··on Ozempic-style drugs now in trials for heart failure, addiction and even aging
I'm saying that the "retatrutide" test subject has no way to access known-good retatrutide.
estearum··on Ozempic-style drugs now in trials for heart failure, addiction and even aging
Profoundly stupid shit.
estearum··on Ozempic-style drugs now in trials for heart failure, addiction and even aging
What's the experiment?

"Person A takes Foundayo, Person B takes mystery drug?"

Not sure what you think you're learning from that.

estearum··on Google has acquired Crusoe's data center site in southeast Wyoming
Do you also get mad when people who are upset about the deficit don't donate extra money to Treasury?

This is a pretty typical coordination problem where people are reluctant to make personal sacrifices when they know others will not make similar sacrifices which are necessary to achieve the goal.

estearum··on Where Each U.S. State Gets Its Tax Revenue From
Yes
estearum··on Where each U.S. state gets its tax revenue from
Land Value Tax does this with effectively zero enforcement complexity and across all forms of communal wealth creation (which ultimately gets baked into land values).
estearum··on I struggle to believe that AI R&D is ingenious
There's no such thing as "pure creativity," which I presume you mean "creative output not directly derived by prior inputs." The very concept is utter nonsense.
estearum··on I struggle to believe that AI R&D is ingenious
This doesn't even address the direct point. The question is how any of this is fundamentally different (difference in type and not just of "scale") from how human cognition works.
estearum··on Infant Bleeding Surged as Parents Rejected Vitamin K Shots, Studies Find
No, that's actually not true. The US is not "extremely well-funded." It's pretty much on-par with other advanced nations adjusted for PPP.
estearum··on Inkling 2 Small
The vast majority of users on this website wouldn't be trusting something coming out of the USA, they'd be trusting something in the USA.
estearum··on Nasdaq Sinks 5% as Investors Retreat from AI Trade After Election
As I understand it, very little of Replit and Lovable (especially) are actually B2C. A lot of it is internal teams at mid-sized companies, which are a huge and demonstrably very fruitful customer segment, and one that Cloudflare does in fact serve already.

Cloudflare has already started releasing products that point in this direction. Not sure how far they will (or should) go, but it's really not categorically ridiculous or impossible or nonsensical, as you're implying.

https://blog.cloudflare.com/cloudflare-os/

estearum··on Nasdaq Sinks 5% as Investors Retreat from AI Trade After Election
The SaaS component of Shopify is also trivial now. That's not where Shopify's moat comes from either. You are very confused.

> Cloudflare's network could be emulated with proper planning and enough budget

lmfao

estearum··on Nasdaq Sinks 5% as Investors Retreat from AI Trade After Election
By this logic every single company on the planet would be a single-product company. The reality is that companies expand their offerings all the time – despite the cost, complexity, and risk of doing so.

A great time to expand your offerings is when there's an adjacent offering that's producing outsized returns for someone else, is easily replicable, and which you have an asymmetric advantage on.

I think everyone knows that when someone says "it's trivial" for a business to do something, it doesn't mean it's actually trivial. Doing anything of any value anywhere is non-trivial. It's shorthand for "doing Activity X is almost certainly achievable with an acceptable outlay of risk for Business Y."

estearum··on Nasdaq Sinks 5% as Investors Retreat from AI Trade After Election
What network effects?

And the reason for Cloudflare to do it is because there are several (apparently) very juicy businesses to be built by slapping a chat UI and off the shelf coding agent on top of Cloudflare infra... Not saying they should do this, but the rationale is pretty self-evident.

The reason for Replit to try going down the stack is platform risk and compressing margins from competitors who also have the brilliant idea of slapping a text box and off the shelf coding agents onto Cloudflare.

estearum··on Nasdaq Sinks 5% as Investors Retreat from AI Trade After Election
I'm not expressing an opinion on whether they should or shouldn't.
← PreviousPage 3 of 34Next →